20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with creatine in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (creatine) | Trials (creatine) | Recent Studies (post-2010) (creatine) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 9,934 | 887 | 2,423 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | creatine (IC50) |
|---|---|---|---|
| Sodium- and chloride-dependent creatine transporter 1 | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, C; Chaykovska, L; Dragun, D; Falck, JR; Flemming, B; Fuller, TF; Gollasch, M; Hoff, U; Ladwig, M; Luft, FC; Lukitsch, I; Manthati, VL; Muller, DN; Schneider, W; Schunck, WH; Seeliger, E | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and creatine
| Article | Year |
|---|---|
Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.
Topics: Acute Kidney Injury; Animals; Apoptosis; Creatine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Epithelial Cells; Hydroxyeicosatetraenoic Acids; Kidney Tubules; Models, Animal; Rats; Rats, Inbred Lew; Reperfusion Injury; Statistics, Nonparametric; Urea | 2011 |